Pierre Fabre Drug Patent Portfolio
Pierre Fabre owns 1 orange book drug protected by 2 US patents Given below is the list of Pierre Fabre's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8338489 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | 16 Oct, 2028 | Active |
| US8987262 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | 16 Oct, 2028 | Active |
Latest Legal Activities on Pierre Fabre's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Pierre Fabre.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 May, 2024 | US8338489 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 May, 2020 | US8338489 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 25 Dec, 2012 | US8338489 |
|
Recordation of Patent Grant Mailed
Critical
| 25 Dec, 2012 | US8338489 |
|
Issue Notification Mailed
Critical
| 05 Dec, 2012 | US8338489 |
| Dispatch to FDC | 29 Nov, 2012 | US8338489 |
|
Application Is Considered Ready for Issue
Critical
| 19 Nov, 2012 | US8338489 |
|
Issue Fee Payment Received
Critical
| 16 Nov, 2012 | US8338489 |
|
Issue Fee Payment Verified
Critical
| 16 Nov, 2012 | US8338489 |
| Response to Reasons for Allowance | 16 Nov, 2012 | US8338489 |
| Supplemental Papers - Oath or Declaration | 13 Nov, 2012 | US8338489 |
| Miscellaneous Incoming Letter | 13 Nov, 2012 | US8338489 |
| Mail Miscellaneous Communication to Applicant | 18 Oct, 2012 | US8338489 |
| Miscellaneous Communication to Applicant - No Action Count | 11 Oct, 2012 | US8338489 |
| Printer Rush- No mailing | 11 Oct, 2012 | US8338489 |
Pierre Fabre Drug Patents' Oppositions Filed in EPO
Pierre Fabre drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Mar 09, 2012, by Infectopharm Arzneimittel Und Consilium Gmbh. This opposition was filed on patent number EP08838691A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP08838691A | Mar, 2012 | Infectopharm Arzneimittel und Consilium GmbH | Opposition rejected |
Pierre Fabre's Family Patents
Pierre Fabre Drug List
Given below is the complete list of Pierre Fabre's drugs and the patents protecting them.
1. Hemangeol
Hemangeol is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8338489 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
16 Oct, 2028
(3 years from now)
| Active |
| US8987262 | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
16 Oct, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hemangeol's drug page